ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China flag China · Delayed Price · Currency is CNY
66.64
-0.06 (-0.09%)
Sep 8, 2025, 11:44 AM CST

SHE:300723 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 2016 - 2020
Operating Revenue
1,0881,4192,4892,2752,1951,675
Upgrade
Other Revenue
33.3930.7614.044.953.820.21
Upgrade
1,1221,4502,5032,2802,1991,675
Upgrade
Revenue Growth (YoY)
-47.84%-42.07%9.79%3.68%31.26%2.32%
Upgrade
Cost of Revenue
566.72576.21481.98300.2321.98297.66
Upgrade
Gross Profit
554.78874.022,0211,9801,8771,378
Upgrade
Selling, General & Admin
767.13829.711,4141,4641,4471,034
Upgrade
Research & Development
253.18312.09301.37189.78142.32135.34
Upgrade
Other Operating Expenses
34.5824.3572.8630.3930.4421.5
Upgrade
Operating Expenses
1,0631,1671,7921,6851,6211,193
Upgrade
Operating Income
-507.93-293.44229.35294.58256.25184.38
Upgrade
Interest Expense
-44.02-35.11-37.65-28.96-38.51-11.75
Upgrade
Interest & Investment Income
13.93.7211.718.4628.9615.08
Upgrade
Currency Exchange Gain (Loss)
0.041.31-5.510.1-0.47-0.09
Upgrade
Other Non Operating Income (Expenses)
2.84-3.28-1.27-1.78-6.41-0.17
Upgrade
EBT Excluding Unusual Items
-535.17-326.79196.63272.4239.82187.44
Upgrade
Impairment of Goodwill
-11.03-11.03----
Upgrade
Gain (Loss) on Sale of Investments
-19.43-40.11-24.64-28.3123.96-
Upgrade
Gain (Loss) on Sale of Assets
1.671.270.120.19-0.070.03
Upgrade
Asset Writedown
-15.77-15.85-1.02-0.45-1.34-0.06
Upgrade
Other Unusual Items
-201.38-253.273.0982.59100.485.88
Upgrade
Pretax Income
-781.1-645.71244.19326.41362.77273.3
Upgrade
Income Tax Expense
-105.59-7992.3964.3269.3649.66
Upgrade
Earnings From Continuing Operations
-675.51-566.71151.8262.1293.41223.64
Upgrade
Minority Interest in Earnings
15.4726.6732.8228.5913.51.97
Upgrade
Net Income
-660.04-540.04184.61290.68306.92225.61
Upgrade
Net Income to Common
-660.04-540.04184.61290.68306.92225.61
Upgrade
Net Income Growth
---36.49%-5.29%36.04%57.02%
Upgrade
Shares Outstanding (Basic)
452452452429422434
Upgrade
Shares Outstanding (Diluted)
452452452433424434
Upgrade
Shares Change (YoY)
0.05%-0.00%4.43%1.94%-2.20%0.64%
Upgrade
EPS (Basic)
-1.46-1.200.410.680.730.52
Upgrade
EPS (Diluted)
-1.46-1.200.410.670.720.52
Upgrade
EPS Growth
---39.18%-7.09%39.10%56.02%
Upgrade
Free Cash Flow
-943.27-870.18123.59-130.25-123.13-38.93
Upgrade
Free Cash Flow Per Share
-2.09-1.930.27-0.30-0.29-0.09
Upgrade
Dividend Per Share
--0.2100.1330.1330.093
Upgrade
Dividend Growth
--57.54%-43.95%24.97%
Upgrade
Gross Margin
49.47%60.27%80.75%86.83%85.36%82.23%
Upgrade
Operating Margin
-45.29%-20.23%9.16%12.92%11.65%11.00%
Upgrade
Profit Margin
-58.85%-37.24%7.37%12.75%13.96%13.47%
Upgrade
Free Cash Flow Margin
-84.11%-60.00%4.94%-5.71%-5.60%-2.32%
Upgrade
EBITDA
-303.13-115.53387.34366.46305.79225.05
Upgrade
EBITDA Margin
-27.03%-7.97%15.47%16.07%13.91%13.43%
Upgrade
D&A For EBITDA
204.81177.91157.9971.8949.5440.68
Upgrade
EBIT
-507.93-293.44229.35294.58256.25184.38
Upgrade
EBIT Margin
-45.29%-20.23%9.16%12.92%11.65%11.00%
Upgrade
Effective Tax Rate
--37.84%19.70%19.12%18.17%
Upgrade
Revenue as Reported
1,1221,4502,5032,2802,1991,675
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.